Efficacy and safety of combined ethinyl estradiol/drospirenone oral contraceptives in the treatment of acne

References

• KilkennyMMerlinKPlunkettAMarksRThe prevalence of common skin conditions in Australian school students: 3. Acne vulgarisBr J Dermatol199813958408459892951
   PubMed Web of Science ®Google Scholar
• LelloJPearlAArrollBYallopJBirchallNMPrevalence of acne vulgaris in Auckland senior high school studentsNZ Med J19951081004287289
   Web of Science ®Google Scholar
• GouldenVStablesGICunliffeWJPrevalence of facial acne in adultsJ Am Acad Dermatol199941457758010495379
   PubMed Web of Science ®Google Scholar
• CollierCNHarperJCCantrellWCWangWFosterKWElewskiBEThe prevalence of acne in adults 20 years and olderJ Am Acad Dermatol2008581565917945383
   PubMed Web of Science ®Google Scholar
• ShawJCWhiteLEPersistent acne in adult womenArch Dermatol200113791252125311559234
   PubMedGoogle Scholar
• KellettSCGawkrodgerDJThe psychological and emotional impact of acne and the effect of treatment with isotretinoinBr J Dermatol1999140227328210233222
   PubMed Web of Science ®Google Scholar
• GuptaMAGuptaAKDepression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasisBr J Dermatol199813958468509892952
   PubMed Web of Science ®Google Scholar
• KrowchukDPStancinTKeskinenRWalkerRBassJAnglinTMThe psychosocial effects of acne on adolescentsPediatr Dermatol1991843323381838809
   PubMed Web of Science ®Google Scholar
• TanJKLLiYFungKDivergence of demographic factors associated with clinical severity compared to QoL impact in acneJ Cutan Med Surg200812523524218845093
   PubMed Web of Science ®Google Scholar
• TanJNew Developments in Hormonal Therapy for AcneSkin Therapy Lett20071271317940710
   PubMedGoogle Scholar
• CarminaELoboRA comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic womenClin Endocrinol (Oxf)200257223123412153602
   PubMed Web of Science ®Google Scholar
• ShawJWhiteLELong-term safety of spironolactone in acne: results of an 8 year followup studyJ Cutan Med Surg20026654154512219252
   PubMed Web of Science ®Google Scholar
• GollnickHCunliffeWBersonDManagement of acne: a report from a global alliance to improve outcomes in acneJ Am Acad Dermatol2003431 SuppS1S3712833004
   PubMed Web of Science ®Google Scholar
• O’ConnellKWesthoffCPharmacology of Hormonal Contraceptives and AcneCutis2008811 Suppl81218338652
   PubMed Web of Science ®Google Scholar
• ThiboutotDRegulation of Human Sebaceous GlandsJ Invest Dermatol2004123111215191536
   PubMed Web of Science ®Google Scholar
• MuhnPKrattenmacherRBeierSElgerWSchillingerEDrospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal modelsContraception1995512991107750297
   PubMed Web of Science ®Google Scholar
• OelkersWBergerVBolikADihydrospirorenone, a new progestogen with antimineralocorticoid activity: Effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal womenJ Clin Endocrinol Metab19917348378421890155
   PubMed Web of Science ®Google Scholar
• KrattenmacherRFrommMMineralocorticoid and antimineralocorticoid effects of various progestogens on electrogenic Na+ transport in the rat distal colon in vitro. [abstract] 36th Symposion of the “Deutsche Gesellschaft fur Endokrinologie.”Acta Endocrinol199212488
   Google Scholar
• FuhrmannUKrattenmacherRSlaterEPFritzemeierKHThe novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potentialContraception19965442432518922878
   PubMed Web of Science ®Google Scholar
• PollowKJuchemMElgerWJacobiNHoffmannGMobusVDihydrospirorenone (ZK 30595): A novel synthetic progestagen-characterization of binding to different receptor proteinsContraception19924665615741493716
   PubMed Web of Science ®Google Scholar
• ElgerWBeierSPollowKGarfieldRShiSQHillischAConception and pharmacodynamic profile of drospirenoneSteroids20036810–1389190514667981
   PubMed Web of Science ®Google Scholar
• LosertWCasals-StenzelJBuseMProgestogens with antimineralocorticoid activityArzneimittelforschung19853524594714039568
   PubMed Web of Science ®Google Scholar
• YAZ drosperinone and ethinyl estradiol tablets. Prescribing information. Bayer Health Care Pharmaceuticals Inc. Wayne, New Jersey. 2007 www.yazus.com/hcp/pdf/Prescribing_Information_Key_Points.pdf Accessed Sept 2009.
   Google Scholar
• SchindlerAECampagnoliCDruckmannRClassification and pharmacology of progestinsMaturitas200346Supp 1S7S1614670641
   PubMed Web of Science ®Google Scholar
• LehmannHLRobinsonKAAndrewsJSHollowayVGoddmanSNAcne therapy: A methodological reviewJ Am Acad Dermatol2002472 Pt 123124012140469
   PubMed Web of Science ®Google Scholar
• Dermatologic and Opthalmic Drugs Advisory Committee Executive summary. 2002 Nov 4–5[about 1 p.]. www.fda.gov/ohrms/dockets/ac/02/briefing/3904B1_02_Executive%20Summary.htm Accessed Sept. 2009.
   Google Scholar
• TanJKCurrent measures for the evaluation of acne severityExp Rev Derm200835595603
   Google Scholar
• WillisSAKuehlTJSpikermanAMSulakPJGreater inhibition of the pituitary-ovarian axis in oral contraceptive regimens with a shortened hormone-free intervalContraception200674210010316860046
   PubMed Web of Science ®Google Scholar
• MaloneyJMDietzePJrWatsonDTreatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trialObstet Gynecol2008112477378118827119
   PubMed Web of Science ®Google Scholar
• KoltunWLuckyAWThiboutotDEfficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trialContraception200877424925618342647
   PubMed Web of Science ®Google Scholar
• MaloneyJMDietzePJrWatsonDA randomized controlled trial of a low-dose combined oral contraceptive containing 3 mg drospirenone plus 20 μg ethinylestradiol in the treatment of acne vulgaris: lesion counts, investigator ratings and subject self-assessmentJ Drugs Dermatol20098983784419746676
   PubMed Web of Science ®Google Scholar
• LuckyAWKoltunWThiboutotDA combined oral contraceptive containing 3 mg drospirenone/20 ug ethinyl estradiol in the treatment of acne vulgaris: a randomized, double-blind placebo-controlled study evaluating lesion counts and participant self assessmentCutis200882214315018792547
   PubMed Web of Science ®Google Scholar
• PiaggioGElbourneDRAltmanDGPocockSJEvansSJWReporting of noninferiority and equivalence randomised trialsJAMA2006295101152116016522836
   PubMed Web of Science ®Google Scholar
• Van VlotenWAvan HaselenCWvan ZuurenEJGerlingerCHeitheckerRThe effect of 2 combined oral contraceptives containing either drosperinone or cyproterone acetate on acne and seborrheaCutis2002694 Suppl21512096825
   PubMedGoogle Scholar
• LuckyAWHendersonTAOlsonWHRobischDMLebwohlMSwinyerLJEffectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgarisJ Am Acad Dermatol1997375 Pt 17467549366821
   PubMed Web of Science ®Google Scholar
• RedmondGPOlsonWHLippmanJSKafrissenMEJonesTMJorizzoJLNorgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trialObstet Gynecol19978946156229083323
   PubMed Web of Science ®Google Scholar
• LeydenJShalitaAHordinsky MswinyerLStanczykFZWeberMEEfficacy of a low-dose oral contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for the treatment of moderate acne: A randomized, placebo-controlled trialJ Am Acad Dermatol200247339940912196750
   PubMed Web of Science ®Google Scholar
• ThiboutotDArcherDFLemayAWashenikKRobertsJHarrisonDDA randomized, controlled trial of a low-dose contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for acne treatmentFertil Steril200176346146811532465
   PubMed Web of Science ®Google Scholar
• ThorneycroftIHGollnickHSchellschmidtISuperiority of a combined contraceptive containing drosperinone to a triphasic preparation containing norgestimate in acne treatmentCutis200474212313015379365
   PubMed Web of Science ®Google Scholar
• SeegerJDLoughlinJEngPMCliffordCRCutoneJWalkerAMRisk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptivesObstet Gynecol2007110358759317766604
   PubMed Web of Science ®Google Scholar
• DingerJCHeinemannLAKühl-HabichDThe safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on oral contraceptives based on 142,475 women-years of observationContraception200775534435417434015
   PubMed Web of Science ®Google Scholar